Hemosorption and polychemotherapy with hyperglycemia in the treatment of ovarian cancer
Lisetskiĭ, V.A.; Evtushenko, G.V.; Dotsenko, I.S.; Svintsitskiĭ, V.S.
Vrachebnoe Delo 4: 87-89
1990
ISSN/ISBN: 0049-6804 PMID: 2125767 Document Number: 364980
Polychemotherapy supplemented by short-time artificial hyperglycemia was carried out in 54 patients with advanced ovarian cancer. For detoxication drugs were used in 27 patients and hemosorption in 27 patients. It was found that hemosorption produced a more detoxifying effect, reduces the frequency of severe complications and allows to improve long-term results.
Document emailed within 1 workday
Related Documents
Sevelda, P.; Dittrich, C.; Salzer, H.; Pateisky, N.; Spona, J. 1986: Monitoring the cytotoxic potential of a sequential polychemotherapy (adriamycin/cisplatin-vincristine/cyclophosphamide-high dose methotrexate) in patients with advanced ovarian cancer with the tumor marker CA-125 Cancer Detection and Prevention 9(5-6): 521-528Zhuchenko, A.P.; Kalganov, I.D.; Filon, A.F.; Totikov, M.Z. 2004: Systemic polychemotherapy in combined treatment of colon cancer Antibiotiki i Khimioterapiia 49(12): 26-30
Amiraliev, N.M. 2002: Neoajuvant polychemotherapy at the complex treatment of the patients with laryngeal cancer Antibiotiki i Khimioterapiia 47(3): 22-25
Bondar', G.V.; Kondratiuk, B.P.; Komendant, V.V.; Gonchar, A.G. 1999: Endolymphatic polychemotherapy in comprehensive treatment of pulmonary cancer after a radical surgery Klinichna Khirurhiia 1: 18-20
Fukuyama, A.; Yokoyama, Y.; Wada, J.; Hashimoto, T.; Oda, T.; Sato, S.; Mizunuma, H. 2009: Two cases of ovarian cancer at an early stage incidentally detected using transvaginal ultrasonography in screening: importance of interval for ovarian cancer screening and selection of population with a high risk of ovarian cancer European Journal of Gynaecological Oncology 30(2): 208-210
Pannuti, F. 1977: Modern prospects in the treatment of cancer of the breast and its metastasis. Medroxyprogesterone in massive doses as an alternative to polychemotherapy Minerva Chirurgica 32(19): 1211-1220
Hartge, P.; Hayes, R.; Reding, D.; Sherman, M.E.; Prorok, P.; Schiffman, M.; Buys, S. 2000: Complex ovarian cysts in postmenopausal women are not associated with ovarian cancer risk factors: preliminary data from the prostate, lung, colon, and ovarian cancer screening trial American Journal of Obstetrics and Gynecology 183(5): 1232-1237
Gadducci, A.; Facchini, V.; Dell'Arciprete, T.; Del Bravo, B.; Galigani, P.; Palla, R.; Fioretti, P. 1988: Evaluation of the renal function in patients with ovarian carcinoma subjected to polychemotherapy including cisplatin or carboplatin Minerva Ginecologica 40(1): 33-38
Penault-Llorca, F.; Levrel, O.; Clémenson, A.; Kwiatkowski, F.; Pomel, C.; Fouilhoux, G.; De Latour, M.; Curé, H.; Déchelotte, P.; Fonck, Y.; Dauplat, J. 2000: Assessment of different histoprognosis grading systems for primary ovarian cancer: 100 patients given the same treatment for primary ovarian adenocarcinoma Journal de Gynecologie Obstetrique et Biologie de la Reproduction 29(6): 548-554
Suzuki, M.; Sekiguchi, I.; Tamada, T.; Sakurabayashi, I.; Kawai, T. 1985: Clinical evaluation of a cancer antigen CA125 associated with ovarian cancer. (III) Serum CA125 levels in patients with ovarian cancer and other gynecological tumors Rinsho Byori. Japanese Journal of Clinical Pathology 33(2): 173-177
Simakhin, I.L. 1992: Reasons for the failures of hemosorption and thrombogenic complications of hemosorption during the venovenous method of setting up the extracorporeal system Anesteziologiia i Reanimatologiia 3: 7-11
Rose, P.G.; Hunter, R.E. 1994: Advanced ovarian cancer in a woman with a family history of ovarian cancer, discovered at referral for prophylactic oophorectomy. A case report Journal of Reproductive Medicine 39(11): 908-910
Tanaka, K. 1989: Ovarian cancer--assessment of methods for cytogenetic analysis and chromosome aberrations found in ovarian cancer Rinsho Byori. Japanese Journal of Clinical Pathology Spec no 80: 268-280
Kashuro, V.A.; Glushkov, S.I.; Zheregelia, S.N. 2010: Cytoflavin in polychemotherapy of breast cancer Antibiotiki i Khimioterapiia 55(7-8): 30-33
Kang, Y.; Xu, C.-j.; Liu, X.-s.; Shao, Z.-m.; Ou, Z.-l.; Luo, J.-m.; Wu, C.-q.; Zhong, C.-p.; Gu, J.-r. 2006: Suicidal cancer vaccine enhances anti-tumor immunotherapeutic effect and its safety in the treatment of ovarian cancer Zhonghua Zhong Liu Za Zhi 28(9): 654-657
Białkowski, J.; Koehler, M. 1989: Hyperglycemia in newborn infants. II. Secondary hyperglycemia in the neonatal period Endokrynologia Polska 40(2): 89-93
Klapdor, R.; Bahlo, M.; Babinski, A.; Broemel, T.; Müller, C.; Seutter, R. 2003: Sequential polychemotherapy in exocrine pancreatic cancer Anticancer Research 23(2a): 841-844
Sighart, H.; Wrbka, E.; Simml, G. 1972: Intermittent polychemotherapy in inoperable bronchial cancer Wiener Medizinische Wochenschrift 122(33): 485-489
Violante, A.; Martinoli, L.; Terzoli, E.; Nisticò, C.; Beciani, M. 1985: Assay of vitamin C in subjects with cancer before and after polychemotherapy Bollettino della Societa Italiana di Biologia Sperimentale 61(7): 983-987
Marino, P.; Pampallona, P.M. 1993: Polychemotherapy in advanced non-small-cell lung cancer Lancet 342(8873): 741; Author Reply 741-2